Recent progress on triterpenoid derivatives and their anticancer potential

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Pharmacology

Background:

• Cancer remains a major global health issue, with current chemotherapy facing challenges like side effects and drug resistance.
• Natural products are vital sources for discovering new pharmaceutical leads and therapeutic strategies.
• Triterpenoids, a class of natural compounds, exhibit diverse biological activities and complex structures, making them attractive for drug development.

Purpose of the Study:

• To review the anticancer properties of triterpenoids and their synthetic analogs.
• To highlight recent advancements in the research and development of triterpenoid-based anticancer agents.
• To explore the potential of triterpenoids as novel therapeutic candidates for cancer treatment.

Main Methods:

• Comprehensive literature review of existing studies on triterpenoids and cancer.
• Analysis of synthesis and phytochemistry of natural and synthetic triterpenoids.
• Summary of structure-activity relationship (SAR) analyses, including molecular simulation techniques.

Main Results:

• Naturally occurring triterpenes and their derivatives demonstrate significant potential as anticancer agents.
• Synthetic analogs of triterpenoids offer opportunities for optimizing therapeutic efficacy and overcoming resistance.
• Recent research indicates a broad spectrum of biological activities relevant to cancer treatment.

Conclusions:

• Triterpenoids and their derivatives represent a promising class of compounds for developing next-generation anticancer drugs.
• Further investigation into their mechanisms of action and in vivo efficacy is crucial for clinical translation.
• Continued exploration of triterpenoid-based therapies could provide valuable alternatives to existing cancer treatments.